NovaBridge Biosciences's total assets for Q4 2025 were ¥1.82B, a decrease of -7.76% from the previous quarter. NBP total liabilities were ¥29.58M for the fiscal quarter, a -77.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.